What Informed Consent Actually Is

Part of Clinical Research Coordinator (CRC) Training: Informed Consent.

About 6 minutes. Free, in your language, no account needed.

Why this matters

Informed consent is the point at which everything you have learned so far becomes one conversation with one person. It is also the area inspectors examine most closely, because it is where the ethical duty and the documentary evidence meet.

The commonest failure is treating consent as a form. It is a process. The form is only its record.

The four elements

Valid consent requires four things, all of them.

Information. The person is told what the study is, what will happen to them, what the risks and possible benefits are, what the alternatives are, how their data will be handled, and what happens if they are harmed.

Comprehension. They actually understood it. This is not satisfied by handing over a document. You have to check.

Voluntariness. The decision is free. No coercion, no pressure, no undue inducement, and no implication that their normal care depends on it.

Documentation. The decision is recorded, in the way the protocol and local law require, before anything study-specific happens.

Remove any one and the consent is not valid, whatever the signature says.

What the participant must be told

Your consent form will be written by the sponsor and approved by the ethics committee, but you should know what it has to cover, because you will be explaining it aloud.

• That this is research, and that participation is voluntary.
• The purpose of the study and roughly how many people will take part.
• The expected duration and the number and length of visits.
• What procedures will happen, and which of them are experimental rather than routine care.
• The reasonably foreseeable risks and discomforts.
• Any benefits that might reasonably be expected — and honesty when there may be none to them personally.
• The alternatives available, including the treatment they would receive if they did not take part.
• How confidentiality will be protected, and who may see their records, including monitors, auditors and regulators.
• Any compensation, and any provision for treatment if they are injured.
• Who to contact with questions about the study, about their rights, and in an emergency.
• That they may withdraw at any time without penalty and without loss of benefits they are otherwise entitled to.
• Any costs to them, and any payments to them.
• Circumstances in which their participation might be ended without their agreement.
• Whether their samples or data may be kept for future research, and on what terms.

Consent is not one moment

The obligation continues throughout the study.

• New information. If something emerges that might affect a person's willingness to continue — new safety findings, a protocol change, a new procedure — they must be told, and usually re-consented on an updated form.
• Changing capacity. A person's ability to decide can change during a long study. So can their circumstances.
• Ongoing agreement. At each visit, the participant is still choosing to be there. Treat it that way.

Who may take consent

Consent must be taken by someone qualified and delegated to do it. That authority is recorded on the delegation log.

Local rules and the protocol determine whether a coordinator may take consent alone, or whether the investigator or another physician must conduct or countersign the discussion. Many protocols require the investigator or a sub-investigator to be involved, particularly where medical questions are likely. Know your study's rule and follow it exactly, because a consent taken by an undelegated person is a serious finding.

Whoever conducts the discussion must be able to answer questions about the study honestly, and must know when to fetch a doctor rather than improvise.

Special situations

Your protocol will address these; here is what to expect.

• People who cannot consent for themselves. A legally acceptable representative consents on their behalf, according to local law. Where the person can still express a view, their assent is sought and their objection respected.
• Children. The parent or guardian consents; the child gives assent in a form appropriate to their age. When a child reaches the age of consent during a long study, they consent for themselves.
• People who cannot read. An impartial witness observes the whole discussion and signs to confirm it was conducted properly and that consent was given freely.
• Emergency situations. Some protocols allow enrollment without prior consent under strictly defined conditions set by law and approved in advance. This is never improvised at the bedside.
• People who do not speak the language of the form. A translated, approved form and a competent interpreter. A family member translating is a last resort, not a plan.

In practice

A man arrives at Northside Clinic having read the VT-201 advertisement. He is enthusiastic, says he does not need to read the form, and asks where to sign.

Nadia does not let him sign. She explains that she has to go through it, and that this is for his protection rather than hers.

Twenty minutes later, she asks him to tell her in his own words what will happen and what the main risks are. He describes the visits accurately. He then says the new tablet is "the better one".

That single sentence is the reason the check exists. He has misunderstood the central point of the study. Nadia goes back over randomization and explains that nobody knows which tablet is better, that this is why the study exists, and that a computer will decide which one he receives.

He signs fifteen minutes later, with an accurate understanding. Nadia records in the source notes what was discussed, that comprehension was checked, that he had time to ask questions, and that he received a copy of the signed form.

An eager signature is not consent. Understanding is.

Key takeaways

• Valid consent requires information, comprehension, voluntariness and documentation, and the absence of any one of them invalidates it regardless of the signature.
• The consent form is the record of a process, not the process itself.
• Participants must be told that participation is voluntary, that they may withdraw at any time without penalty, and who may access their records including monitors, auditors and regulators.
• Consent is continuing, so new safety information or a protocol change normally requires re-consent on an updated, approved form.
• Only a person delegated on the log may take consent, and many protocols additionally require an investigator or sub-investigator to conduct or countersign the discussion.